Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Wave Life Sci Ord Sh (WVE)

Wave Life Sci Ord Sh (WVE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,108,224
  • Shares Outstanding, K 154,134
  • Annual Sales, $ 108,300 K
  • Annual Income, $ -97,010 K
  • EBIT $ -126 M
  • EBITDA $ -117 M
  • 60-Month Beta -1.04
  • Price/Sales 10.29
  • Price/Cash Flow N/A
  • Price/Book 6.48

Options Overview Details

View History
  • Implied Volatility 89.81% ( +3.64%)
  • Historical Volatility 70.75%
  • IV Percentile 42%
  • IV Rank 31.31%
  • IV High 195.68% on 07/18/24
  • IV Low 41.55% on 06/27/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 6
  • Volume Avg (30-Day) 91
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 3,961
  • Open Int (30-Day) 3,263

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.28
  • Number of Estimates 7
  • High Estimate -0.26
  • Low Estimate -0.32
  • Prior Year -0.25
  • Growth Rate Est. (year over year) -12.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.89 +22.24%
on 05/23/25
7.45 -3.36%
on 06/11/25
+0.60 (+9.09%)
since 05/12/25
3-Month
5.28 +36.36%
on 04/09/25
10.91 -34.01%
on 03/26/25
-3.61 (-33.40%)
since 03/12/25
52-Week
4.25 +69.41%
on 06/27/24
16.74 -56.98%
on 11/11/24
+0.81 (+12.68%)
since 06/12/24

Most Recent Stories

More News
Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference

WVE : 7.20 (+0.14%)
Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer

WVE : 7.20 (+0.14%)
Wave Life Sciences: Q1 Earnings Snapshot

Wave Life Sciences: Q1 Earnings Snapshot

WVE : 7.20 (+0.14%)
Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update

WVE : 7.20 (+0.14%)
Wave Life Sciences First Quarter 2025 Financial Results Scheduled for May 8, 2025

WVE : 7.20 (+0.14%)
Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531

WVE : 7.20 (+0.14%)
Wave Life Sciences: Q4 Earnings Snapshot

Wave Life Sciences: Q4 Earnings Snapshot

WVE : 7.20 (+0.14%)
Wave Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

WVE : 7.20 (+0.14%)
Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025

WVE : 7.20 (+0.14%)
Wave Life Sciences Announces Initiation of Phase 1 INLIGHT Clinical Trial of WVE-007 in Obesity

WVE : 7.20 (+0.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

WAVE Life Sciences Pte. Ltd. is a preclinical biopharmaceutical company. It designs, develops and commercializes nucleic acid therapeutic candidates for Huntington's disease, Duchenne muscular dystrophy and inflammatory bowel disease. Huntington's disease, the Company has programs targeting HTT SNP-1...

See More

Key Turning Points

3rd Resistance Point 7.58
2nd Resistance Point 7.43
1st Resistance Point 7.31
Last Price 7.20
1st Support Level 7.04
2nd Support Level 6.89
3rd Support Level 6.77

See More

52-Week High 16.74
Fibonacci 61.8% 11.97
Fibonacci 50% 10.49
Fibonacci 38.2% 9.02
Last Price 7.20
52-Week Low 4.25

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar